Innovent Biologics (1801N) Cash flow

1 Followers

Innovent Biologics Cash Flow

MX:1801N's free cash flow for Q2 2026 was ¥0.00. For the 2026 fiscal year, MX:1801N's free cash flow was decreased by ¥9.74B and operating cash flow was ¥0.00. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	¥ 10.00B	¥ 1.29B	¥ 147.81M	¥ -1.92B	¥ -2.02B
Investing Cash Flow	¥ -6.51B	¥ -1.17B	¥ -998.66M	¥ -1.44B	¥ -2.70B
Financing Cash Flow	¥ 4.73B	¥ -606.63M	¥ 2.59B	¥ 2.89B	¥ 5.00B
End Cash Position	¥ 10.38B	¥ 2.27B	¥ 2.75B	¥ 1.02B	¥ 1.36B
Free Cash Flow	¥ 9.32B	¥ -418.39M	¥ -1.24B	¥ -3.30B	¥ -3.87B

Currency in CNY